Thymosin Alpha-1 Reconstitution Guide
Part of the full Thymosin Alpha-1 guide - a immunomodulatory thymic peptide reference compound, identity-verified with a COA on every vial.
In brief
This section describes the laboratory principle for reconstituting lyophilized Thymosin alpha-1 to a defined molar stock concentration for in-vitro use. It is a bench-preparation procedure for assay material only and is not a human dosing protocol. The governing quantity is molar concentration, which is computed from the peptide mass supplied, the diluent volume added, and the peptide's molecular weight of 3108.32 g/mol (formula C129H215N33O55). Because the linear sequence carries no cysteines and no disulfide bonds, there is no intramolecular disulfide to protect during handling, which simplifies the reconstitution relative to cysteine-bearing peptides; the N-acetylated, hydrophilic, glutamate/aspartate-rich sequence is otherwise handled by standard gentle peptide practice. Bacteriostatic water is the diluent referenced for laboratory reconstitution.
The detail
A closer look
01
Concentration math and the no-disulfide simplification
The target stock concentration is derived by dividing the labeled peptide mass by the volume of bacteriostatic water added, then converting that mass-per-volume value to molarity using the molecular weight 3108.32 g/mol. Working assay concentrations are then reached by serial dilution of the stock into culture medium or assay buffer. Because the sequence is documented to contain no cysteines and no disulfide bonds, the preparation does not require the reductant controls or oxidation-monitoring steps that a disulfide-bridged peptide would; gentle dissolution and standard cold storage are the operative precautions. All concentrations prepared this way are for in-vitro/ex-vivo experimental systems, never for personal use.
Step by step
How Thymosin Alpha-1 is reconstituted
A bench reference for handling and preparation in an in-vitro research setting. Not a personal dosing protocol.
- 1
Equilibrate the sealed lyophilized Thymosin alpha-1 vial and the bacteriostatic water diluent to room temperature before opening, to limit condensation on the cold peptide.
- 2
Calculate the target stock concentration from the labeled peptide mass and the diluent volume you will add; use the molecular weight 3108.32 g/mol to convert the resulting mass-per-volume concentration to molarity.
- 3
Sanitize the vial septum and draw the predetermined volume of bacteriostatic water with a clean syringe or pipette.
- 4
Add the diluent slowly down the inner wall of the vial onto the lyophilized cake rather than directly onto it, to reduce shear on the peptide.
- 5
Allow the peptide to dissolve undisturbed, then swirl gently (do not vortex or shake vigorously) until the solution is clear, indicating full reconstitution.
- 6
Verify and record the exact peptide mass and final volume so the molar concentration of the stock is documented and traceable.
- 7
Prepare assay working concentrations by serial dilution of the stock into culture medium or assay buffer for the in-vitro system in use.
- 8
Aliquot the stock into single-use volumes to avoid repeated freeze-thaw, label each with concentration and date, and store cold per general peptide handling practice.
The fine print: products are sold for laboratory research use only and are not for human or animal consumption. Bodily introduction into humans or animals is strictly prohibited by law. Thymosin Alpha-1 is not a drug and is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA.